Trustlife Ventures

Trustlife is a Turkish, locally funded health technology investment initiative focused on advancing original medicines and other healthcare technologies from research toward commercialization. Through Trustlife Ventures, a venture capital investment fund, it supports projects selected by scientific committees and aims to establish companies that can share the value created with researchers and inventors. Its funding process combines scientific and financial assessment, project budgeting, and support for company formation, with intellectual property held by inventors and the companies established with the fund.

The group operates Trustlife Labs, an Istanbul-based pharmaceutical research and development center that received official R&D center status in April 2023. Its facilities provide drug-design and preclinical research services, including computational chemistry and biology, medicinal chemistry, cell, tissue and organ culture, and formulation. Capabilities include molecular modeling, compound synthesis and characterization, biological activity and toxicity testing, and drug-delivery development. Trustlife’s research approach uses multi-omics, systems biology and artificial intelligence to identify biomarkers and drug targets, and to coordinate preclinical work.